The future of hepatitis C among people who inject drugs

Main stage
In programme
Wednesday, 23 October, 2019 - 13:20 to 14:50
View presentations

Chair

Hedrich
Dagmar
  • EMCDDA
Duffell
Erika
  • European Centre for Disease Prevention and Control
  • Sweden

Tracks

Keywords

Presentations

  • Plenary session
  • Poster session
  • Big debate
  • Structured session
  • Workshop
  • Oral presentation session
  • Short communication session
  • Poster guided tour

Wednesday, 23 October

13:20
Oral presentation

The epidemiology of drug use and hepatitis C — Where are we now?

13:20 to 13:35
Main stage
Sarah Larney
13:35
Oral presentation

What future strategies will enhance integration of care for drug use and hepatitis C?

13:35 to 13:50
Main stage
Jason Grebely
13:50
Oral presentation

How can modelling inform future interventions to integrate hepatitis C care and drug user health?

13:50 to 14:05
Main stage
Matthew Hickman
14:05
Oral presentation

What is the future role of policy makers to facilitate better integration of hepatitis C and drug user health?

14:05 to 14:20
Main stage
Ricardo Baptista Leite
14:20
Oral presentation

What is required for better integration of hepatitis C and drug user health in the future: a community perspective?

14:20 to 14:35
Main stage
Mauro Guarinieri
14:35

INHSU Connecting with Care Video: Meaningful involvement of people with lived experience in HCV care delivery

14:35 to 14:40
Main stage
View the programme